|

CNP-103 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Treatment

Pipeline

Phase 1/2: 1

Top Sponsors

  • COUR Pharmaceutical Development Company, Inc.1

Indications

  • Type 1 Diabetes Mellitis1
  • Type 1 Diabetes Patients1
  • Type 1 Diabetes (Juvenile Onset)1
  • Type 1 Diabetes in Children1
  • Type 1 Diabetes in Adolescence1

Tucson, Arizona1 trial

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Wake Research - Tucson

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.